Can your Child's doctor treat anxiety? a new approach puts it to the test

NCT ID NCT06104904

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This pilot trial tests whether pediatric primary care providers can effectively deliver a brief intervention called the Anxiety Action Plan (AxAP) to help children aged 6-17 with elevated anxiety symptoms. Providers receive training and coaching to administer the intervention, which is based on exposure therapy strategies. The study compares this approach to enhanced usual care, which includes educational videos and handouts. The goal is to see if this model is feasible and acceptable to providers and families, potentially improving access to anxiety care in community settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Anxiety Action Plan (AxAP), a brief behavioral intervention based on exposure therapy, delivered by pediatric primary care providers
What this could lead to
If effective, this approach could expand access to anxiety care for children by equipping primary care providers to deliver brief, evidence-based interventions, especially in areas with few mental health specialists.
What could go wrong
This is a small pilot trial focused on feasibility, not proof of effectiveness. The intervention may not produce meaningful improvements in child anxiety outcomes, and results may not generalize to broader settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UConn Health

    West Hartford, Connecticut, 06119, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.